Adhera Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Adhera Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2023.
  • Adhera Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2023 was 5.17M shares, a 63.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 5.17M +2.01M +63.5% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 3.84M -59.3M -93.9% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 3.18M -14.3M -81.8% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 3.16M +2.31M +270% Dec 31, 2022 10-Q 2023-11-20
Q3 2022 3.16M -11.3M -78.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 63.1M +51.3M +436% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 17.5M +5.86M +50.4% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 854K -10.3M -92.3% Dec 31, 2021 10-K 2023-03-31
Q3 2021 14.5M +3.62M +33.3% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 11.8M +916K +8.43% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 11.6M +761K +7% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 11.1M +243K +2.24% Dec 31, 2020 10-K 2022-04-15
Q3 2020 10.9M 0 0% Sep 30, 2020 10-Q 2020-11-18
Q2 2020 10.9M 0 0% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 10.9M +108K +1% Mar 31, 2020 10-Q 2020-07-06
Q4 2019 10.9M +108K +1% Dec 31, 2019 10-K 2021-04-07
Q3 2019 10.9M -372K -3.31% Sep 30, 2019 10-Q 2019-11-19
Q2 2019 10.9M -372K -3.31% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 10.8M +240K +2.28% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 10.8M +240K +2.29% Dec 31, 2018 10-K 2020-04-14
Q3 2018 11.2M +1.22M +12.2% Sep 30, 2018 10-Q 2018-11-19
Q2 2018 11.2M +1.4M +14.3% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 10.5M -86.6M -89.2% Mar 31, 2018 10-Q 2018-05-18
Q4 2017 10.5M +1.54M +17.2% Dec 31, 2017 10-K 2019-04-16
Q3 2017 10M -17.7M -63.8% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 9.84M -19.9M -66.9% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 97.1M +67.8M +232% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 8.98M -49.4M -84.6% Dec 31, 2016 10-K 2018-04-17
Q3 2016 27.7M +1.25M +4.74% Sep 30, 2016 10-Q 2016-11-21
Q2 2016 29.8M +3.31M +12.5% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 29.3M +3.64M +14.2% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 58.4M +32.9M +129% Dec 31, 2015 10-K 2017-03-31
Q3 2015 26.5M +703K +2.73% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 26.5M +818K +3.19% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 25.6M +39.6K +0.16% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 25.5M +8.59M +50.7% Dec 31, 2014 10-K 2016-03-30
Q3 2014 25.7M +8.81M +52% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 25.6M +8.7M +51.3% Jun 30, 2014 10-Q 2014-08-19
Q1 2014 25.6M +8.67M +51.2% Mar 31, 2014 10-Q 2014-08-19
Q4 2013 16.9M 0 0% Dec 31, 2013 10-K 2015-02-18
Q3 2013 16.9M +771K +4.77% Sep 30, 2013 10-Q 2014-08-07
Q2 2013 16.9M +4.6M +37.2% Jun 30, 2013 10-Q 2014-08-07
Q1 2013 16.9M +4.78M +39.3% Mar 31, 2013 10-Q 2014-08-07
Q4 2012 16.9M +6.5M +62.3% Dec 31, 2012 10-Q 2014-08-07
Q3 2012 16.2M -72.8M -81.8% Sep 30, 2012 10-Q 2012-12-05
Q2 2012 12.3M -52M -80.8% Jun 30, 2012 10-Q 2012-12-05
Q1 2012 12.2M Mar 31, 2012 10-Q 2012-12-05
Q4 2011 10.4M +7.66M +275% Dec 31, 2011 10-K 2014-08-05
Q3 2011 88.9M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 64.3M Jun 30, 2011 10-Q 2011-08-11
Q4 2010 2.78M Dec 31, 2010 10-K 2012-10-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.